CD4 and cancer: In the GTEM-SEMI-CVID Registry, older age, immune dysregulation, previous immunosuppressant therapies, higher IgM levels, and lower CD4 cell counts at diagnosis were independently associated to malignancy in CVID from a multivariable approach (Figure 2).